A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumoursSarah P. Blagden, Mark R. Middleton, L. Rhoda Molife et al.|British Journal of Cancer|2008Cited by 82